Cardinal Health, Inc. (NYSE:CAH) – Investment analysts at Leerink Swann decreased their Q1 2018 earnings per share estimates for shares of Cardinal Health in a report released on Wednesday. Leerink Swann analyst D. Larsen now forecasts that the company will post earnings of $1.06 per share for the quarter, down from their previous estimate of $1.16. Leerink Swann currently has a “Hold” rating and a $72.00 price target on the stock.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same quarter in the prior year, the company earned $1.14 EPS. The firm’s quarterly revenue was up 5.0% on a year-over-year basis.

TRADEMARK VIOLATION NOTICE: “Research Analysts Offer Predictions for Cardinal Health, Inc.’s Q1 2018 Earnings (CAH)” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/08/07/research-analysts-offer-predictions-for-cardinal-health-inc-s-q1-2018-earnings-cah.html.

Several other equities analysts have also issued reports on the stock. BidaskClub lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday. UBS AG restated a “neutral” rating and issued a $76.00 target price (down previously from $79.00) on shares of Cardinal Health in a report on Thursday. Cowen and Company restated a “market perform” rating and issued a $77.00 target price (down previously from $82.00) on shares of Cardinal Health in a report on Thursday. Credit Suisse Group dropped their target price on shares of Cardinal Health from $87.00 to $81.00 and set an “outperform” rating on the stock in a report on Thursday. Finally, Jefferies Group LLC restated a “hold” rating and issued a $77.00 target price on shares of Cardinal Health in a report on Thursday, July 27th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $80.46.

Shares of Cardinal Health (NYSE:CAH) opened at 69.14 on Monday. Cardinal Health has a 52-week low of $62.70 and a 52-week high of $84.90. The company has a market cap of $21.85 billion, a PE ratio of 17.16 and a beta of 0.80. The company has a 50 day moving average of $77.38 and a 200-day moving average of $77.27.

Several large investors have recently bought and sold shares of the company. River Road Asset Management LLC increased its stake in Cardinal Health by 28.9% in the first quarter. River Road Asset Management LLC now owns 885,861 shares of the company’s stock valued at $72,242,000 after buying an additional 198,554 shares during the last quarter. Bank of Montreal Can increased its stake in Cardinal Health by 6.2% in the first quarter. Bank of Montreal Can now owns 609,732 shares of the company’s stock valued at $49,725,000 after buying an additional 35,436 shares during the last quarter. CWM LLC increased its stake in Cardinal Health by 15.6% in the first quarter. CWM LLC now owns 331,531 shares of the company’s stock valued at $27,036,000 after buying an additional 44,689 shares during the last quarter. Morgan Stanley increased its stake in Cardinal Health by 24.6% in the first quarter. Morgan Stanley now owns 2,035,339 shares of the company’s stock valued at $165,981,000 after buying an additional 402,151 shares during the last quarter. Finally, Iowa State Bank increased its stake in Cardinal Health by 3.4% in the first quarter. Iowa State Bank now owns 20,569 shares of the company’s stock valued at $1,677,000 after buying an additional 675 shares during the last quarter. 87.09% of the stock is owned by institutional investors.

In other news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the business’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the completion of the sale, the insider now directly owns 55,440 shares of the company’s stock, valued at $4,039,912.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.94% of the stock is currently owned by corporate insiders.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.